(GMDA) – FDA
-
Gamida Cell (GMDA) Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
-
Gamida Cell (GMDA) Reports First Patient Receives Omisirge
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GMDA Stock Lookup